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Summary
Background:  Sepsis  syndrome  is  a  major  worldwide  cause  of  morbidity  and  mortal-
ity.  While  community-acquired  severe  sepsis  and  septic  shock  constitutes  a major
cause  of  admission  to  the  intensive  care  unit,  hospital-acquired  severe  sepsis  and
septic  shock  remain  major  preventable  causes  of  ICU  admission.  This  study  evaluates
the  rate,  etiology,  complication  and  outcome  of  community-  and  hospital-acquired
sepsis  in  a  tertiary  care  hospital  in  Saudi  Arabia.
Method:  This  is  a  retrospective  evaluation  of  all  admissions  with  severe  sepsis  and
septic  shock  to  a  general  intensive  care  unit  over  a  period  of  six  months.
Results:  A  total  number  of  96  patients  were  included,  which  represented  15%
of  the  total  number  of  admissions  during  the  study  period.  The  mean  age  was
rcent  of  cases  were  due  to  hospital-acquired  infections,57.4  (SD  21).  Sixty  pe
and  40%  were  community-acquired.  The  majority  of  the  infections  acquired  in
the  hospital  occurred  in  medical  wards  and  intensive  care  units  (27%  and  21%,
respectively).  At  least  one  co-morbid  condition  was  present  in  94%  of  the  sam-
ple  patients,  with  cardiovascular  disease  and  diabetes  being  the  most  frequently
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encountered  disorders  (58%).  Both  community  and  hospital-acquired  severe  sepsis  and
septic  shock  carry  very  high  mortality  (58%).  The  ICU  length  of  stay  was  signiﬁcantly
longer  for  hospital  and  ICU  acquired  infections.
Conclusion:  Both  community  and  hospital-acquired  infections  carry  high  mortality.
 sepsis  is  frequent  in  medical  wards  and  ICUs,  and  measures
factors  are  prudent.
vier  Limited  on  behalf  of  King  Saud  Bin  Abdulaziz  University
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an acute  circulatory  failure  attributed  to  sepsis
that is  not  explained  by  any  other  causes.  Acute
circulatory  failure  is  deﬁned  as  persistent  arterialHospital-acquired  severe
to  further  evaluate  risk  
©  2015  Published  by  Else
for  Health  Sciences.
ackground
epsis  syndrome  is  a  major  worldwide  cause  of  mor-
idity and  mortality.  Twenty  to  forty  percent  of
eptic  patients  who  require  treatment  in  an  inten-
ive care  unit  developed  sepsis  outside  the  hospital
1—3].  Sepsis  occurs  in  approximately  2—10%  of
ospitalized patients,  and  20—50%  of  critically  ill
atients will  develop  at  least  one  episode  of  sepsis
uring  their  admission  [4,5].
The sepsis  incidence  is  increasing.  In  the  late
970s, it  was  estimated  that  164,000  cases  of  sep-
is occurred  in  the  United  States  each  year  [6]. This
tatistic  has  dramatically  increased  within  the  last
ecade, with  more  recent  estimates  suggesting  that
ore than  650,000  cases  of  sepsis  are  diagnosed
nnually in the  United  States  [7]. A  recent  study
erformed in  the  United  States  showed  an  increase
n the  number  of  hospitalized  cases  of  severe  sepsis
rom  415,280  in  2003  to  711,736  in  2007,  which  is  a
1% increase,  with  an  annual  growth  rate  of  17.8%
er year  [8].  A  similar  increase  in  sepsis  incidence
as observed  in  other  parts  of  the  world,  and  hospi-
alizations  for  sepsis  have  more  than  doubled  over
he last  decade  [2,9—13].
The overall  mortality  of  sepsis  syndrome  is
0—60% [1].  Mortality  rates  increased  stepwise
ccording to  sepsis  severity,  averaging  7%  in  sys-
emic inﬂammatory  response  syndrome  to  46%  in
eptic shock  [14,15].  Data  obtained  from  the  SOAP
tudy, which  was  mostly  performed  in  developed
uropean countries,  reported  an  ICU  mortality  of
2.2% in  patients  with  severe  sepsis,  54.1%  in
atients  with  septic  shock,  and  65%  in  patients
ith four  or  more  organ  failures  [10]. Mortality  for
ommunity-acquired  severe  sepsis  and  septic  shock
as lower,  at  23%  and  28%,  respectively,  while  that
f hospital-acquired  sepsis  that  developed  inside
r outside  the  ICU  exhibited  53%  mortality  [14,15].
ortunately,  the  overall  case-fatality  of  sepsis  has
eclined  over  the  last  decade  due  to  advances  in
upportive  care  and  the  implementation  of  bundled
are processes  and  low  tidal  volume  ventilation  in
h
r
aatients  with  acute  respiratory  distress  syndrome
ARDS).
However, little  is  known  regarding  the  incidence
nd outcome  of  hospital  versus  community-
cquired  severe  sepsis  and  shock  requiring  ICU
dmission  in  Saudi  literature.  In  a point  prevalence
tudy performed  by  Balkhy  et  al.,  community-
cquired and  hospital-acquired  infections  preva-
ence was  13.5%  and  8%,  respectively  [16].
This is a retrospective  study  that  evaluates  all
f the  cases  admitted  to  the  intensive  care  unit  in
 major  tertiary  referral  hospital  in  Saudi  Arabia,
hich  fulﬁll  the  diagnostic  criteria  of  severe  sepsis
nd septic  shock  over  a  6-month  period.
atients and methods
ll  patients  admitted  to  King  Abdulaziz  Medical
ity’s general  intensive  care  unit  fulﬁlling  the
eﬁnition  of  severe  sepsis  or  septic  shock  from
eptember 1,  2010  to  February  28,  2011  were
ncluded. This  is  a  mixed  medico-surgical  and
rauma 21-bed  unit  with  an  annual  admission  rate
f 942  patients.  Severe  sepsis  is  deﬁned  as  sepsis
ssociated with  organ  dysfunction,  hypoperfusion
r hypotension  [17]. Organ  dysfunction  variables
nclude arterial  hypoxemia  (PaO2/FIO2  <  300),
cute  oliguria  (urine  output  < 0.5  mL/kg/h  despite
uid resuscitation),  serum  creatinine  >  2.0  mg/dL,
oagulation  abnormalities  (INR  >  1.5  or  aPTT  >  60  s),
latelet count  <  100,000  L−1,  and  plasma  total
ilirubin >  2.0  mg/dL.  Tissue  perfusion  vari-
bles include  hyperlactatemia  (>4  mmol/L).
emodynamic  variables  include  arterial  hypoten-
ion (SBP  <  90  mmHg,  MAP  < 70  mmHg,  or  SBP
ecrease > 40  mmHg).  Septic  shock  is deﬁned  asypotension  (SBP  <  90  mmHg,  MAP  <  60  mmHg,  or  a
eduction in  SBP  >  40  mmHg  from  baseline  despite
dequate volume  resuscitation)  [17]. The  included
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patients  had  a  clinical  suspicion  of  an  infection
source and  either  an  acute  circulatory  failure  or  a
serum lactate  level  above  4 mmol/L  as  well  as  at
least one  of  the  severe  sepsis  criteria.
Infections were  considered  to  be  community-
acquired  if  the  patient  had  no  hospital  admissions
in the  two  weeks  prior  to  the  current  admission,
while infections  manifesting  >  48  h  after  admission
were deﬁned  as  hospital-acquired  infection  (HAI).
Infections  developed  while  in  the  critical  care  unit
were deﬁned  as  infections  resulting  in  severe  sep-
sis and  septic  shock,  which  were  not  present  within
the ﬁrst  48  h of  admission.
The data  collection  included  age,  gender,
co-morbidities,  community  or  hospital-acquired
infection,  site  of  infection  acquisition,  sepsis  eti-
ology,  complications,  ICU  length  of  stay,  and
mortality. We  also  compared  patients  with  commu-
nity,  hospital  and  ICU  acquired  infections.
Statistical analysis
Data  were  entered  using  a  Microsoft  Excel  spread-
sheet, which  was  then  transferred  using  the
Statistical Package  for  Social  Sciences  (SPSS),  which
was used  for  data  management  and  analyses.
Descriptive analyses  were  performed  by  reporting
the number  and  percentage  for  categorical  vari-
ables,  whereas  the  mean  and  standard  deviation
were reported  for  continuous  values.  Associations
between the  groups  and  categorical  variables  were
performed  using  the  Chi-square  test,  whereas  the
independent  Student’s  t-test  was  used  to  assess  the
association  with  continuous  variables.  A  p-value  of
<0.05 was  considered  to  indicate  statistical  signiﬁ-
cance.
Results
A  total  number  of  96  patients  fulﬁlled  the  enroll-
ment criteria  of  severe  sepsis  and  septic  shock,
which represented  15%  of  the  total  number  of
admissions.  The  mean  age  was  57.4  (SD  21).  There
were 61  males  and  35  females.
At least  one  co-morbid  condition  was  present  in
94% of  the  patients,  with  cardiovascular  disease
and diabetes  being  the  most  frequently  encoun-
tered (40%  and  33%,  respectively).  Hypertension,
ischemic heart  disease  and  congestive  cardiac
failure were  the  most  frequently  present  cardiovas-
cular co-morbidities.  Chronic  respiratory  illnesses
were the  third  leading  morbidity  occurring  in  24%
of the  patients,  followed  by  chronic  liver  diseases
in 18%  of  patients  (Table  1).
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Hospital-acquired  infections  resulting  in  severe
epsis and  septic  shock  occurred  in  60%  of  this
atient population,  and  community  infections
ccurred in  40%.  The  majority  of  patients  were
dmitted  from  medical  wards  (27%),  while  infec-
ion developed  in  the  ICU  occurred  in  21%  of
atients.
A respiratory  source  of  infection  was  the  leading
ause for  both  hospital-  and  community-acquired
nfections,  occurring  in  45%  and  40%,  respectively.
he second  most  common  source  was  intra-
bdominal infections,  at  12%;  followed  by  urinary
ract infections,  at  6%.  Respiratory  samples  were
btained  from  the  majority  of  intubated  patients
dmitted  with  severe  sepsis  regardless  of  the  sus-
ected source  of  sepsis.  Staphylococcus  aureus  and
aemophilus  inﬂuenzae  were  the  most  frequently
solated, followed  by  klebsiella  pneumoniae, while
seudomonas  and  acinetobacter  spp.  were  the  most
ommon among  patients  with  hospital-acquired
epsis. Mycobacterium  tuberculosis  was  isolated
n two  patients  with  community-acquired  sepsis,
nd Mycobacterium  Avium  Complex  (MAC)  and
spergillus  spp.  were  isolated  in  two  patients  with
ospital-acquired  sepsis.
All patients  had  at  least  one  set  of  blood  cul-
ures at  the  time  of  sepsis  diagnosis.  Of  the  patients
ith community-acquired  sepsis,  13%  of  the  blood
ultures  were  positive,  with  Coagulase  Negative
taphylococcus (CNS)  being  the  most  frequently
solated, followed  by  Escherichia  coli  (E.  coli)
nd Streptococcus  viridans.  Among  patients  with
ospital-acquired  sepsis,  the  yield  was  18%  with
seudomonas  aeruginosa, followed  by  Candida  spp.
nd Coagulase  Negative  Staphylococcus  aureus  as
he most  frequently  isolated.
Diagnosis  of  severe  sepsis  and  septic  shock  was
linically  based  in  22%,  while  an  organism  was
solated  in  77%  of  the  patients.  Klebsiella  pneumo-
iae,  Methicillin  Sensitive  Staphylococcus  Aureus
MSSA), Streptococcus  pneumoniae  and  E.  coli
ere the  most  frequently  isolated  organisms  in
ommunity-acquired  sepsis.  In  hospital-acquired
epsis, Pseudomonas  aeruginosa  was  the  leading
rganism  isolated,  followed  by  Acinetobacter  spp.
nd Enterobacter  spp.  Gram-negative  organisms
ere the  leading  cause  of  respiratory  infections  in
oth community-  and  hospital-acquired  infections.
rucella  spp  was  isolated  from  pleural  ﬂuid  in  one
atient.
Both community-  and  hospital-acquired  severe
epsis and  septic  shock  have  high  mortality  rates,
7.2% and  63%,  respectively.  The  mean  length  of
tay in  the  ICU  was  signiﬁcantly  shorter  in  the  group
ith community-acquired  sepsis  (10.6  d  vs.  21.6  d,
 =  .03)  (Table  1).
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Table  1  Comparison  between  community  and  hospital  acquired  severe  sepsis.
Variable  Whole  group  Infection  type  p
Community-acquired  severe
sepsis  and  septic  shock
Hospital-acquired  severe
sepsis  and  septic  shock
Mean  age 57.28  (SD  20.95) 57.26  (SD20.65) 57.3  (SD21.3) .9
Male  61  (63.5%)  23  (63.9%)  38  (63.3%)  .95
Female  35  (36.5%)  13  (36.1)  22  (36.7%)
Co-morbidities  90  (93.8%)  32(88.9%)  58  (96.7%)  .19
Diabetes  31  (32.3%)  12  (33.3%)  19  (31.7%)  .86
Chronic  liver  disease  18  (18.1%)  8  (22.2%)  10  (16.7%)  .5
Chronic  respiratory
disease
23  (24%)  6  (16.7%)  17  (28.3%)  .19
Neurological  15  (15.6%)  4  (11.1%)  11  (18.3%)  .34
Cardiovascular
disease
38  (39.4%)  14  (38.9%)  24  (40%)  .9
Chronic  renal
disease
14  (14.3%)  7  (19.4%)  7  (11%)  .29
Hematological
malignancies
12  (12.5%)  3  (8.3%)  9  (15%)  .34
Malignancy  10  (10.4%)  4  (11%)  6  (10%)  .8
Complications
Renal  failure
requiring  HD
19 (19.8%)  7  (19.4%)  12  (20%)  .94
Renal  failure  not
requiring  HD
16 (16.7%)  6  (18.7%)  10  (16.7%)  1
Respiratory
failure/MV
80  (83%)  30  (83.3%)  50  (83.3%)  .7
ARDS  43  (44.8%)  17  (47.2%)  26  (43.3%)  .93
Hepatic  dysfunction  13  (13.5%)  5  (13.9%)  8  (13.3%)  .65
DIC  32  (33.3%)  13  (36.1%)  19  (31.7%)  .54
ICU  outcome  55  (57.3%)  17  (47.2%)  36  (63.3%)  .12
Mean  LOS  17.19  (SD  20.24)  10.6  21.6  .03
SOFA  score  day  one  10.25  (SD  3.616)  10.06  10.37  .6
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Comparisons  were  made  between  severe  sepsis
eveloped in  the  ICU  and  that  of  outside  critical
rea and  sever  sepsis  acquired  outside  ICU  including
ommunity acquired  with  that  acquired  in  hospital
nd in  ICU  (Tables  2  and  3).  There  were  no  signif-
cant differences  between  the  two  groups  in  age,
ender,  existing  co-morbidities,  and  admission  and
ay-3 Sequential  Organ  Failure  Assessment  (SOFA)
cores.
Acute kidney  injury  (AKI)  requiring  hemodialysis
ccurred more  commonly  in  patients  with  septic
hock developed  in  critical  care  (26.3%  vs.  18.4%,
 =  0.94).  Conversely,  AKI  that  did  not  require
emodialysis was  observed  more  in  the  group  devel-
ping sepsis  outside  critical  care  (21.1%  vs.  10.5%,
 =  1).  Other  complications  observed  in  the  group
f developing  sepsis  in  critical  care  included  adult
espiratory  distress  syndrome  (57.9%  vs.  39.5%,
 =  0.93),  DIC  (42.1%  vs.  26.3,  p  =  0.54)  and  liver
ysfunction (21%  vs.  10.5%,  p  =  0.65).  The  overall
A
B
a
r9.75  .74
ortality  was  similar  in  both  groups.  Patients
dmitted to  the  ICU  with  severe  sepsis  had  a
horter length  of stay  compared  with  those  who
eveloped  sepsis  while  in  the  ICU  (mean  =  15.3  vs.
4.4, p =  0.001).
iscussion
epsis  is one  of  the  most  common  causes  of  admis-
ion to  critical  care  units  worldwide.  However,
ata comparing  admissions  to  critical  care  for
ospital  versus  community  infections  with  regard
o the  patient’s  characteristics,  rate,  and  spec-
rum of  sepsis  and  of  complications  and  outcome
n Saudi  critical  care  units  are  lacking.  In  Saudi
rabia and  as  shown  in  a study  performed  by
alkhy et  al.,  community-acquired  and  nosocomial
cquired infections  prevalence  were  13.5%  and  8%,
espectively  [16].
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Table  2  Comparison  between  hospital  severe  sepsis  occurring  in  ICU  and  outside.
Variable  Sepsis  outside  critical  care  Sepsis  in  critical  care  p
Mean  age  58.75  (SD19.84)  58.6  (SD  24.9)  .38
Male  45  (59.2%)  16  (80%)
.86Female  31  (31%)  4  (20%)
Co-morbidities  71  (93%)  19  (95%)  .6
Diabetes  55  (72.4%)  10  (50%)  .57
Chronic  liver  disease 17  (22.4%) 1  (5%) .08
Chronic  respiratory  disease 15  (19.7%) 8  (40%) .06
Neurological  11  (14.5%) 4  (20%) .5
Cardiovascular  disease  29  (38.2%)  9  (45%)  .7
Chronic  renal  disease  14  (18.4%)  0  .04
Hematological  malignancies  10  (13.2%)  2  (10%)  .7
Malignancy  10  (13.2%)  0  .08
Complications
Renal  failure  requiring  HD 14  (18.4%) 5  (25%) .5
Renal  failure  not  requiring  HD 14  (18.4%) 2  (10%) .36
Respiratory  failure/MV  32  (42.1%)  15  (75%)  .26
ARDS  65  (85.5%)  11  (55%)  .3
Hepatic  dysfunction  9  (11.8%)  4  (10%)  .34
DIC  24  (31.6%)  8  (40%)  .47
ICU  Outcome  42  (55.3%)  13  (65%)  .08
Mean  LOS  12  34.42  .001
SOFA  score  day  one  10.75  9.05  .09
SOFA  score  day  3  10.11  7.75  .07
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dSevere  sepsis  and  septic  shock  accounted  for  15%
of admissions  to  our  critical  care  unit.  The  pro-
portion of  patients  with  severe  sepsis  among  ICU
admissions  varied  from  9%  to  27%  [1,9], averaging
10—12% in  most  studies  [11—13]. In  the  European
SOAP study,  a  notable  difference  was  found  in
the ICU  admissions  between  different  countries.
Switzerland had  the  lowest  (10%)  and  Portugal  the
highest (64%)  severe  sepsis  rates  among  ICU  admis-
sions [10].  This  may  represent  the  population’s  vari-
ation or  reﬂect  the  high  prevalence  of  nosocomial
infection at  the  time  of  the  study.  Seasonal  vari-
ability  has  been  previously  well  documented  [18].
The high  prevalence  of  co-morbidities  in  our
study is  likely  explained  by  both  the  tertiary  care
setting  and  high  mean  age  of  this  cohort  popula-
tion. Cardiovascular  diseases  are  the  most  common
co-morbidities  encountered,  followed  by  diabetes
mellitus  (DM)  and  chronic  respiratory  diseases,
which occur  at  39.4%,  31%  and  24%,  respectively.
Saudi communities  have  a  high  prevalence  of  DM
and cardiovascular  disease.  Chronic  liver  disease,
as a  co-morbidity,  is  common  in  our  study,  which
also reﬂect  a  tertiary  setting  in  that  we  are  one
of the  only  two  liver  transplant  centers  in  Saudi
Arabia.
In this  retrospective  study,  60%  of  severe  sepsis
and septic  shock  cases  occurred  secondary  to  health
a
R
tare  related  infections,  while  40%  were  community-
cquired. The  reported  relative  distribution  of
hese two  broad  causes  varies  according  to  the
eographical  and  critical  care  setting.  In  a prospec-
ive study  in  a tertiary  care  medico-surgical  ICU
n Finland,  Ylipalosaari  et  al.  reported  that  40.7%
f their  severe  sepsis  and  septic  shock  cases  were
ue to  hospital-acquired  infections  [19]. While  in
 prospective,  observational,  cross-sectional  1-day
oint-prevalence  study  performed  in  454  ICUs  in
ermany,  39.1%  of  the  infections  were  community-
ased, while  13.8%  were  of  nosocomial  origin;  of
hese 32.9%  were  of  intensive  care  origin  [13].
osocomial  infections  of  ICU  origin  represented
p to  46.6%  in  greater  than  600  bed  hospitals
13]. Our  study  is  unique  in  showing  that  infec-
ions acquired  in  medical  wards  exceeded  those
cquired  in  intensive  care.  This  may  be  related  to
he high  population  of  elderly  patients  with  high
isk of  aspiration  in  our  medical  wards.  The  respi-
atory source  of  severe  sepsis  and  septic  shock  was
he most  commonly  encountered,  which  was  simi-
ar to  many  previous  epidemiological  studies  from
ifferent  parts  of  the  world.
The rate  of  complications  from  severe  sepsis
nd the  septic  shock  rate  in  our  study  was  high.
espiratory failure  requiring  mechanical  ventila-
ion is  the  most  frequent  complication,  occurring
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Table  3  Comparison  of  severe  sepsis  occurring  in  different  hospital  settings.
Variable  Community  and
non-ICU  acquired
sepsisa
Sepsis  acquired  in
critical  care
p Sepsis  acquired  in
hospital
Sepsis  acquired  in
critical  care
p
Mean  age  59.15  (SD19.3)  58.6  (SD  24.9)  .3  58.75  (SD19.84)  58.6  (SD  24.9)  .38
Male  22  (55%) 16  (80%)  .06  45  (59.2%)  16  (80%)
.86Female  18  (45%) 4  (20%) 31  (31%)  4  (20%)
Co-morbidities  29  (97.5%) 19  (95%) .6  71  (93%) 19  (95%) .6
Diabetes  9  (22.5%) 10  (50%) .03  55  (72.4%) 10  (50%) .57
Chronic  liver
disease
9 (22.5%)  1  (5%)  .08  17  (22.4%)  1  (5%)  .08
Chronic
respiratory
disease
9  (22.5%)  8  (40%)  .15  15  (19.7%)  8  (40%)  .06
Neurological  7  (17.5%)  4  (20%)  .8  11  (14.5%)  4  (20%)  .5
Cardiovascular
disease
15  (37.5%)  9  (45%)  .5  29  (38.2%)  9  (45%)  .7
Chronic  Renal
disease
7 (17.5%)  0  .04  14  (18.4%)  0  .04
Hematological
malignancies
7  (17.5%)  2  (10%)  .4  10  (13.2%)  2  (10%)  .7
Malignancy  6  (15%) 0  .07  10  (13.2%)  0  .08
Complications
Renal  failure
requiring  HD
7 (17.5%)  5  (25%)  .5  14  (18.4%)  5  (25%)  .5
Renal  failure  not
requiring  HD
8 (20%)  2  (10%)  .4  14  (18.4%)  2  (10%)  .36
Respiratory
failure/MV
35  (87%)  15  (75%)  .27  32  (42.1%)  15  (75%)  .26
ARDS  15  (37.5%)  11  (55%)  .26  65  (85.5%)  11  (55%)  .3
Hepatic
dysfunction
4  (10%)  4  (10%)  .2  9  (11.8%)  4  (10%)  .34
Thrombocytopenia  11  (27.5%)  8  (40%)  .2  24  (31.6%)  8  (40%)  .47
ICU  Outcome 25 (62.5%)  13  (65%)  .85  42  (55.3%)  13  (65%)  .08
Mean  LOS 15.32  34.42  .01  12  34.42  .001
SOFA  score  day
one
11.03  (SD3.42)  9.05  (SD3.87)  .04  10.75  9.05  .09
SOFA  score  day  3 10.75  (SD5.03) 7.75  (SD4.15) .01  10.11  7.75  .07
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ra Non-ICU acquired sepsis refers to sepsis acquired in hospit
n  83%  of  patients,  of  which  more  than  50%  fulﬁlled
he ARDS  criteria.  Acute  kidney  injury  occurred  in
9.4% of  patients,  of  whom  more  than  one-third
equired renal  replacement  therapy.  Patients  with
evere sepsis  and  septic  shock  represented  the  sick-
st group  in  the  spectrum  of  sepsis  syndrome,  which
ad a  high  mortality  and  complication  rate.
Community-acquired  and  hospital-acquired
nfection,  resulting  in  severe  sepsis  and  septic
hock, both  shared  a  high  mortality  rate.  The
mall number  of  enrolled  patients  in  our  own
tudy partially  explains  the  non-signiﬁcant  rate  of
ortality between  the  two  groups  (48.7%  versus
7.4%).
When comparing  groups  with  severe  sepsis  that
eveloped  while  in  the  ICU  to  those  admitted  to
m
r
t
ords.
he  ICU  with  severe  sepsis  from  general  wards,
he former  group  had  a  higher  SOFA  score  upon
dmission and  lower  SOFA  on  day  3  as  well  as  a
onger  length  of  stay.  Similar  results  to  our  ﬁnd-
ngs were  reported  by  Ylipalosaari  et  al.  in  their
rospective  study  of  383  patients  admitted  for  more
han 48  h to  a mixed  medico-surgical  ICU  [19]. How-
ver, the  mean  SOFA  score  was  lower  than  that
eported in  our  study.  Consistent  with  our  ﬁndings,
he SOFA  score  was  higher  in  patients  with  infec-
ions acquired  in  the  ICU.  However,  they  did  not
eport  a SOFA  score  after  72  h.  In  their  study,  the
ean length  of  stay  was  shorter  than  the  value
eported in  our  study  for  all  age  groups.  In  addi-
ion, the  mean  average  SOFA  score  was  lower  than
ur patient  population.
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Conclusion
In summary,  our  study  is  among  the  very  few  pub-
lished  studies  from  Saudi  Arabia  that  addresses
the occurrence  and  outcome  of  hospital-  versus
community-acquired  severe  sepsis  and  septic
shock. Hospital-acquired  sepsis  occurs  unaccept-
ably frequently  in  our  hospital  and  is  associated
with a  high  mortality  and  increased  length  of  stay.
Thus, measures  to  further  evaluate  risk  factors  are
prudent.
Funding
No  funding  sources.
Competing interests
The  authors  declare  that  they  have  no  conﬂict  of
interest.
Ethical approval
Not  required.
References
[1] Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente
JA, Gordo F, et al. Sepsis incidence and outcome: con-
trasting the intensive care unit with the hospital ward. Crit
Care Med 2007;35:1284—9.
[2] Beale R, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Mar-
tin G, et al. Promoting Global Research Excellence in Severe
Sepsis (PROGRESS): lessons from an international sepsis reg-
istry. Infection 2009;37:222—32.
[3] Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman
S, Artigas A, et al. Epidemiology of sepsis and infection
in ICU patients from an international multicentre cohort
study. Intensive Care Med 2002;28:108—21.
[4] Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni
S, et al. Epidemiology and outcome of sepsis syndromes in
Italian ICUs: a muticentre, observational cohort study in the
region of Piedmont. Minerva Anestesiol 2013;79:993—1002.
[5] Ott E, Saathoff S, Graf K, Schwab F, Chaberny IF. The preva-
lence of nosocomial and community acquired infections in
[
Available  online  at  www
ScienceDS.  Baharoon  et  al.
a university hospital: an observational study. Dtsch Arztebl
Int 2013;110:533—40.
[6] Shubin H, Weil MH. Bacterial shock. JAMA 1976;235:421—4.
[7] Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G,
Carcillo J, Pinsky MR. Epidemiology of severe sepsis
in the United States: analysis of incidence, outcome,
and associated costs of care. Crit Care Med 2001;29:
1303—10.
[8] Lagu T, Rothberg MB, Shieh M-S, Pekow PS, Steingrub JS,
Lindenauer PK. Hospitalizations, costs, and outcomes of
severe sepsis in the United States 2003 to 2007. Crit Care
Med 2012;40:754—61.
[9] Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K.
Epidemiology of severe sepsis occurring in the ﬁrst 24 hrs
in intensive care units in England, Wales, and Northern
Ireland. Crit Care Med 2003;31:2332—8.
10] Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Ger-
lach H, et al. Sepsis in European intensive care units: results
of the SOAP study. Crit Care Med 2006;34:344—53.
11] Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh
J. Adult-population incidence of severe sepsis in Australian
and New Zealand intensive care units. Intensive Care Med
2004;30:589—96.
12] Van Gestel A, Bakker J, Veraart CP, van Hout BA. Prevalence
and incidence of severe sepsis in Dutch intensive care units.
Crit Care 2004;8:R153—62.
13] Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H,
Grond S, et al. Epidemiology of sepsis in Germany: results
from a national prospective multicenter study. Intensive
Care Med 2007;33:606—18.
14] Park DW, Chun BC, Kim JM, Sohn JW, Peck KR, Kim YS.
Epidemiological and clinical characteristics of community-
acquired severe sepsis and septic shock: a prospective
observational study in 12 university hospitals in Korea. J
Kor Med Sci 2012;27:1308—14.
15] Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J,
Micek ST, et al. Epidemiology, microbiology and out-
comes of healthcare-associated and community-acquired
bacteremia: a multicenter cohort study. J Infect
2011;62:130—5.
16] Balkhy HH, Cunningham G, Chew FK, Francis C, Al Nakhli
DJ, Almuneef MA, et al. Hospital- and community-acquired
infections: a point prevalence and risk factors survey in
a tertiary care center in Saudi Arabia. Int J Infect Dis
2006;10:326—33.
17] Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal
SM, et al. Surviving sepsis campaign: international guide-
lines for management of severe sepsis and septic shock:
2012. Crit Care Med 2013;41:580—637.
18] Danai PA, Sinha S, Moss M, Haber MJ, Martin GS. Sea-
sonal variation in the epidemiology of sepsis. Crit Care Med
2007;35:410—5.
19] Ylipalosaari P, Ala-Kokko TI, Laurila J, Ohtonen P, Syrjälä H.
Community- and hospital-acquired infections necessitating
ICU admission: spectrum, co-morbidities and outcome. J
Infect 2006;53:85—92.
.sciencedirect.com
irect
